Breast cancer screening – DCIS and the COMET trial

Women diagnosed with Ductal Carcinoma in Situ (DCIS) are usually offered lumpectomy or mastectomy as standard treatment, although DCIS is not usually recognised as an actual cancer, but rather cell changes which may or may not become cancerous in the future. In an attempt to combat overtreatment of women diagnosed with DCIS, the prospective, randomised clinical trial, COMET, (Comparison of Operative to Medical Endcrine Therapy) will test whether or not active surveillance (as offered in prostate cancer) with close monitoring would be a safe option.

Laurie McGinley. Waiting and watching with ‘Stage O’ cancer put to nationwide test.


About bmitzi

Medical writer, author, artist. Cancer campaigner. Aiming always to improve health services and bring compassion into health care.
This entry was posted in Breast Cancer, breast screening, Campaigns, citizen safety, clinical trials, Compassion in healthcare, harms, healthcare modernisation, information, informed consent, mastectomy, medicine's flaws, Over-medicalisation, overdiagnosis, overtreatment, patient safety, patient/doctor communication, Screening, Screening Mammography and tagged , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s